ME Therapeutics Holdings Inc. (CSE:METX)

ME Therapeutics Holdings Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 21, 2026	Aug 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021
Market Capitalization	90	118	69	-	-	-
Market Cap Growth	-39.07%	70.86%	-	-	-	-
Enterprise Value	90	117	68	-	-	-
Last Close Price	3.00	4.00	2.75	-	-	-
PB Ratio	139.74	78.74	46.94	-	-	-
P/TBV Ratio	139.74	78.74	46.94	-	-	-
Debt / Equity Ratio	0.04	0.05	-	0.08	-1.46	-3.40
Debt / FCF Ratio	-	-	-	-	-	17.86
Net Debt / Equity Ratio	-0.79	-0.89	-1.01	-1.16	-0.88	0.74
Net Debt / EBITDA Ratio	0.33	1.07	1.09	0.62	-0.76	0.19
Net Debt / FCF Ratio	0.40	1.23	2.28	2.00	-0.85	-3.89
Quick Ratio	3.87	6.00	24.05	4.41	0.57	2.27
Current Ratio	3.91	6.12	24.45	4.52	0.59	2.27
Return on Equity (ROE)	-111.03%	-80.11%	-129.52%	-3327.53%	-	-2126.14%
Return on Assets (ROA)	-69.00%	-48.35%	-77.65%	-157.78%	-106.78%	-60.78%
Return on Capital Employed (ROCE)	-240.40%	-84.30%	-93.10%	-186.70%	212.60%	-167.10%
Earnings Yield	-1.53%	-1.01%	-1.87%	-	-	-
FCF Yield	-1.43%	-0.91%	-0.95%	-	-	-
Buyback Yield / Dilution	-11.85%	-14.17%	-55.90%	-84.08%	-39.53%	-0.07%

Data Source: S&P Global Market Intelligence Last updated: May 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 18, 2026

Data Sources Report a data error